NIOSHTIC-2 Publications Search

Advanced Search   Search Help   About NIOSHTIC-2    Feedback

Lithium toxicity.

Authors
Thundiyil JG
Source
CALL US... 2003 Nov; 1(6):1-5
Link
http://www.calpoison.org/hcp/2003/callusvol1no6.html
NIOSHTIC No.
20037230
Abstract
The medical use of lithium has evolved considerably since it was first used for gout and rheumatism in the 1800's. It was also used as a salt substitute in patients with hypertension, and was at one point present in the soft drink 7-Up. In the 1970's, the US FDA approved the use of lithium for the treatment of acute mania following studies in the 1950's by Cade and Schou. Currently, lithium is used to treat a variety of disorders including cluster headaches, alcoholism, and Grave's disease. Lithium is most commonly used, however, as the treatment of choice for recurrent bipolar disorder (manic-depressive illness).
Keywords
Biological-effects; Chemical-hypersensitivity; Chemical-properties; Drug-interaction; Drugs; Emergency-care; Emergency-treatment; Exposure-assessment; Exposure-methods; Health-care-facilities; Health-care-personnel; Medical-rescue-services; Medical-services; Medical-treatment; Physiological-effects; Physiological-response; Risk-analysis; Risk-factors; Statistical-analysis; Work-practices
CAS No.
7439-93-2
Publication Date
20031101
Document Type
Newsletter
Funding Type
Grant
Fiscal Year
2004
Identifying No.
Grant-Number-T42-OH-008429
Issue of Publication
6
Source Name
CALL US... The Official Newsletter of the California Poison Control System
State
CA; FL
Performing Organization
University of California, Berkeley
Page last reviewed: May 11, 2023
Content source: National Institute for Occupational Safety and Health Education and Information Division